Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

VisiVite Announces AREDS Vitamins Inhibit Diabetes-Related Vision Loss in Rats

Researchers Find That Micronutrients in AREDS-recommended formula reduce cases of diabetic retinopathy in laboratory tests. The AREDS formula is already in use to treat macular degeneration.

Huntington, NY (PRWEB) October 2, 2008 -- The same vitamin formula recommended by the National Eye Institute to slow the progress of age-related macular degeneration has been shown to prevent diabetic retinopathy in rats, according to study results released in the September 2008 Archives of Ophthalmology.

Researchers from the Kresge Eye Institute and Wayne State University conducted research into the effects of macular degeneration treatments on vision loss due to diabetic retinopathy. Macular degeneration, which affects more than 10 million Americans, is caused by the thinning of the macula. Diabetic retinopathy is vision loss caused by microvascular retinal changes as a symptom of the progress of diabetes mellitus. Both ocular conditions cause progressive vision loss, eventually leading to blindness if untreated. Diabetes mellitus affects 2.8% of the worldwide population.

In the study, rats were given a diet containing powdered micronutrients based on the results of the NEI's Age-Related Eye Disease Study (AREDS). These nutrients include zinc, beta-carotene and vitamins A, C and E. The retina was studied after the rats had diabetes for a period of 12 months. A control group that did not receive the micronutrient powder was also used.

The AREDS vitamins prevented an increase in of acellular capillary development in the retina of the subjects. The same rats also did not reflect an increase in retinal oxidative and nitrative stress; oxidative stress is also believed to be a key factor in macular degeneration.

VisiVite.com manufactures macular degeneration vitamin supplements with antioxidants like Lutein, Zeaxanthin and beta-carotene to help individuals with AMD, or those at risk for AMD, to delay or stop the progress of central vision loss.

About VisiVite.com:

Since 2001, VisiVite.com is dedicated to providing customers with state of the art macular degeneration vitamins to lessen the risk of age-related macular degeneration. Their products include several VisiVite Omega-3 eye supplements, AREDS Vitamins (http://www.visivite.com/idefensegold.html) and Dry Eye Relief Vitamins (http://www.visivite.com/dry-eye-relief-tear-stabilization-formula.html). For more information and up-to-the minute AMD news, visit VisiVite.com.

Contact:

VisiVite.com

1-800-427-7660

http://www.visivite.com

###

Simillar Articles

VisiVite.com Files for Patent on Unique Macular Degeneration Supplement
Removal of Vitamin E from High Dose Eye Vitamins Provides Safety for Certain Patients.
As Macular Degeneration Treatment Halts, Eye Health Supplements Still Proven Treatment
Studies show anecortave acetate treatments had no effect on the progress of age-related eye condition; eye health supplements from VisiVite.com still linked to control, prevention of AMD.
VisiVite.com Presents New Study Results Confirming Eye Health Benefits of Omega-3 Fatty Acids
The Findings of a New AJCN Study Indicate That Dietary Fish Consumption Reduces Risk of Age-Related Macular Degeneration, Supporting VisiVite.com's Research Into The Effects of Omega-3 Fatty...
Maker of Ocular Multivitamins Points to Benefits of Omega-3 Fatty Acids as Highlighted in Macular...
VisiVite.com, makers of multivitamins to improve ocular health, points to new report linking high intake of fatty acids associated with 38% reduction in AMD risk; groundbreaking VisiVite Eye...
VisiVite.com Presents New Study Findings: Antioxidants Halt and Prevent Macular Degeneration
A New Study Published In Journal of Biological Chemistry Reasserts the Benefit of Antioxidants On Macular Degeneration and Traces a Link Between the Disease and Cell Damage Caused By Oxidation.
Home Terms of Use Privacy Policy Contact Us